Now showing items 1-4 of 4

    • An integrated approach to the prediction of chemotherapeutic response in patients with breast cancer. 

      Acharya, CR; Anders, CK; Anguiano, A; Barry, WT; Dressman, HK; Garman, Katherine S; Marcom, Kelly; ... (14 authors) (PLoS One, 2008-04-02)
      BACKGROUND: A major challenge in oncology is the selection of the most effective chemotherapeutic agents for individual patients, while the administration of ineffective chemotherapy increases mortality and decreases quality ...
    • Gene expression signatures that predict radiation exposure in mice and humans. 

      Chao, Nelson J; Chute, JP; Dressman, HK; Ginsburg, Geoffrey Steven; Marshall, D; Meadows, Sarah K; Muramoto, Garrett G; ... (8 authors) (PLoS Med, 2007-04)
      BACKGROUND: The capacity to assess environmental inputs to biological phenotypes is limited by methods that can accurately and quantitatively measure these contributions. One such example can be seen in the context of exposure ...
    • Modulation of murine breast tumor vascularity, hypoxia and chemotherapeutic response by exercise. 

      Betof, AS; Devi, GR; Dewhirst, Mark Wesley; Jones, LW; Landon, C; Lascola, Christopher David; Palmer, Gregory M; ... (9 authors) (J Natl Cancer Inst, 2015-05)
      Exercise has been shown to improve postischemia perfusion of normal tissues; we investigated whether these effects extend to solid tumors. Estrogen receptor-negative (ER-, 4T1) and ER+ (E0771) tumor cells were implanted ...
    • Outcomes and costs of autologous stem cell mobilization with chemotherapy plus G-CSF vs G-CSF alone. 

      Bernard, LM; Brown, S; Carrum, G; Chao, Nelson J; Grima, DT; Holmberg, L; Horwitz, Mitchell; ... (13 authors) (Bone Marrow Transplant, 2013-11)
      Chemotherapy plus G-CSF (C+G) and G-CSF alone are two of the most common methods used to mobilize CD34(+) cells for autologous hematopoietic SCT (AHSCT). In order to compare and determine the real-world outcomes and costs ...